Abstract: Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Abstract: Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Abstract: The present embodiment provides a method and system a method for sharing Mobile Equipment Identification Number (MEID) and Mobile Index Number (MIN) to provide optimal communication in a multi-service provider environment. The method includes receiving a request to access a service provided by one or more service providers, identifying a MEID-MIN pair associated with the request, and sharing the identified MEID-MIN pair among a plurality of access nodes associated with the one or more service providers. Further, the method further includes detecting an optimized access node among the plurality of access nodes to provide access to the service based on parameters associated with the plurality of access nodes, and using the identified MEID-MIN pair to provide access to the service through the detected optimized access node.

Abstract: The proposed embodiment provides a method and system for load balancing between one or more nodes and a plurality of backhaul links over a communication network. The method includes computing processing data of the node(s) using parameters associated with the node, and computing backhaul link loading data using parameters associated with the plurality of backhaul links. Further, the method includes analyzing the processing data and the backhaul link loading data using one or more rules, and determining whether load balancing is required in accordance to the analysis. Furthermore, the method includes performing one or more actions in the communication network to load balance between the node and the plurality of backhaul links in response to determining that the load balancing is required.

Abstract: A mixer/feeder wagon (1) for mixing and dispensing batches of animal feed comprises a device (50) for monitoring operation of the mixer/feeder wagon (1) and for determining instants during a mixing cycle during which ingredients of the animal feed are to be loaded into the mixer/feeder wagon (1). The mixer/feeder wagon (1) comprises a mixing compartment (14) within which a paddle mixer (17) is rotatable for mixing the ingredients of the batch of animal feed therein. Load sensors (9) produce signals indicative of the current weight of the ingredients in the mixing compartment (14) which are read by a microprocessor (55) of the device (50). A proximity sensor (38) counts the number of revolutions of the paddle mixer 17.

Abstract: Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Abstract: Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1 and R2 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Abstract: The present invention provides compounds of Formula I, and the tautomers thereof, and the pharmaceutically acceptable salts of the compounds and tautomers, wherein the compounds have the structure wherein the variables R1, R2, R3, R4 and x are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Abstract: The proposed embodiment provides a method and system for automatically detecting an optimal device over a network. The method includes receiving parameters associated with devices in the network, prioritizing the received parameters based on one or more rule, and detecting an optimized device based on the assigned priorities of the parameters associated with the devices.

Abstract: The proposed embodiment provides a method and system for automatically versioning machine to machine (M2M) network applications. The method and system includes receiving information about applications associated with each node in the network, determining new versions of the applications based on the received information and versioning the new versions of the applications on each node in the network.

Abstract: The proposed embodiment provides a method and system for automatically optimizing services in a network. The method includes receiving parameters associated with services of one or more devices in the network, prioritizing the parameters associated with the services in accordance to a plurality of rules, and selecting an optimized service associated with the devices based on the assigned priorities of the parameters associated with the services.

Abstract: The proposed embodiment provides a method and system for enhancing efficiency of a communication terminal. The method includes configuring short-range communication and long-range communication in the communication terminal, receiving parameters associated with a node in a communication network, and switching among the short-range communication and the long-range communication within a data session based on the received parameters.

Abstract: The proposed embodiment provides a method and system for automatically generating machine to machine (M2M) network applications. The method and system includes receiving information about one or more nodes in the network and generating one or more applications for the one or more nodes based on the information.

Abstract: A method and system to share credentials of the user automatically with the selected external wireless device in the wireless network is disclosed. The method selects the external wireless device based on the parameters and avail the services of the external wireless device in the user home wireless device. The external wireless devices are connected with a different service provider and when the user request to access the service in an external wireless device, then the method selects the optimum external wireless device among plurality of external wireless devices.

Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1 and R2 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Abstract: The present invention provides compounds of Formula I, and the tautomers thereof, and the pharmaceutically acceptable salts of the compounds and tautomers, wherein the compounds have the structure wherein the variables R1, R2, R3, R4 and x are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1 and R2 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Abstract: The present invention provides compounds of Formula I, and the tautomers thereof, and the pharmaceutically acceptable salts of the compounds and tautomers, wherein the compounds have the structure wherein the variables R1, R2, R3, R4 and x are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Abstract: Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.